Workflow
Quantum BioPharma Licensee Celly Nutrition Expands unbuzzd™ Alcohol Detox Product Lineup for Retail Sales
QNTMQuantum Biopharma Ltd.(QNTM) Newsfilter·2025-03-26 11:00

Core Viewpoint - Quantum BioPharma Ltd. announced the launch of new unbuzzd™ "On-the-Go Powder Stick Packs" in 8-pack display boxes, aimed at enhancing retail availability and sales in the U.S. market for hangover cure products, which is valued at approximately 2.1billion[1][5][10].ProductDetails−unbuzzd™isnowavailableinvariousformatsincluding3−packs,8−packs,and18−packs,withthe8−packdesignedforeasyportabilityandcompliancewithTSAregulations[2][4].−Thecompactdesignandeye−catchingpackagingofthe8−packdisplayboxmakeitappealingforretailerstosellatcheckoutlocations[4][5].MarketStrategy−Theintroductionofthe8−packdisplayboxisexpectedtomeetdiverseconsumerneedsandaccelerateretailavailability,therebyboostingsalesandprofitsforretailers[5].−Theproductaimstoleverageimmediateavailabilityinconvenience,liquor,anddrugstoresasakeygrowthdriver[5][10].ClinicalValidation−Arecentclinicaltrialdemonstratedtheeffectivenessofunbuzzd™inreducingbloodalcoholconcentration,restoringmentalclarity,andalleviatinghangoversymptoms[6][10].−Theproductisscientificallybackedbyadouble−blind,randomized,placebo−controlledclinicaltrial[10].FinancialArrangement−QuantumBioPharmaretainsa25.712.1 billion [1][5][10]. Product Details - unbuzzd™ is now available in various formats including 3-packs, 8-packs, and 18-packs, with the 8-pack designed for easy portability and compliance with TSA regulations [2][4]. - The compact design and eye-catching packaging of the 8-pack display box make it appealing for retailers to sell at checkout locations [4][5]. Market Strategy - The introduction of the 8-pack display box is expected to meet diverse consumer needs and accelerate retail availability, thereby boosting sales and profits for retailers [5]. - The product aims to leverage immediate availability in convenience, liquor, and drug stores as a key growth driver [5][10]. Clinical Validation - A recent clinical trial demonstrated the effectiveness of unbuzzd™ in reducing blood alcohol concentration, restoring mental clarity, and alleviating hangover symptoms [6][10]. - The product is scientifically backed by a double-blind, randomized, placebo-controlled clinical trial [10]. Financial Arrangement - Quantum BioPharma retains a 25.71% ownership stake in Celly Nutrition and has established a royalty agreement of 7% on unbuzzd™ sales until total payments reach 250 million, after which the royalty rate will decrease to 3% [6][12]. Corporate Update - Quantum BioPharma has engaged TD Media LLC to enhance market awareness for a fee of $55,000 over a 45-day period starting March 26, 2025 [8].